In this editor’s desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what’s still to be done.

It’s a sign of the times when experts develop climate risk reporting platforms that assess the vulnerability of a company’s physical sites to 28 climate change hazards.

EcoAct, an Atos company, has today released its 12^th Annual Corporate Climate Reporting Performance Report. Despite rapid progress in 2021 during the lead up to COP26, the 2022 report, which assesses how international businesses across the FTSE, DOW, DAX, CAC, FTSE MIB and IBEX are tackling climate-related sustainability challenges, found that less than half (48%) of FTSE 100 businesses achieved Scope 1 & 2 emissions reductions in line with 1.5°C, in comparison to 72% in 2021.   

EcoAct, an Atos company, has today released its 12^th Annual Corporate Climate Reporting Performance Report. Despite rapid progress in 2021 during the lead up to COP26, the 2022 report, which assesses how international businesses across the FTSE, DOW, DAX, CAC, FTSE MIB and IBEX are tackling climate-related sustainability challenges, found that less than half (48%) of FTSE 100 businesses achieved Scope 1 & 2 emissions reductions in line with 1.5°C, in comparison to 72% in 2021.